PT  - JOURNAL ARTICLE
AU  - Tsugawa, Yusuke
AU  - Takahashi, Osamu
AU  - Meigs, James B.
AU  - Davis, Roger B.
AU  - Imamura, Fumiaki
AU  - Fukui, Tsuguya
AU  - Taylor, William C.
AU  - Wee, Christina C.
TI  - New Diabetes Diagnostic Threshold of Hemoglobin A<sub>1c</sub> and the 3-Year Incidence of Retinopathy
AID  - 10.2337/db12-0103
DP  - 2012 Dec 01
TA  - Diabetes
PG  - 3280--3284
VI  - 61
IP  - 12
4099  - http://diabetes.diabetesjournals.org/content/61/12/3280.short
4100  - http://diabetes.diabetesjournals.org/content/61/12/3280.full
SO  - Diabetes2012 Dec 01; 61
AB  - The new diagnostic threshold of hemoglobin A1c was made based on evidence from cross-sectional studies, and no longitudinal study supports its validity. To examine whether hemoglobin A1c of 6.5% or higher defines a threshold for elevated risk of incident retinopathy, we analyzed longitudinal data of 19,897 Japanese adults who underwent a health checkup in 2006 and were followed up 3 years later. We used logistic regression models and restricted cubic spline models to examine the relationship between baseline hemoglobin A1c levels and the prevalence and the 3-year incidence of retinopathy. The restricted cubic spline model indicated a possible threshold for the risk of incident retinopathy at hemoglobin A1c levels of 6.0–7.0%. Logistic regression analysis found that individuals with hemoglobin A1c levels of 6.5–6.9% were at significantly higher risk of developing retinopathy at 3 years compared with those with hemoglobin A1c levels of 5.0–5.4% (adjusted odds ratio, 2.35 [95% CI 1.08–5.11]). Those with hemoglobin A1c levels between 5.5 and 6.4% exhibited no evidence of elevated risks. We did not observe a threshold in the analysis of prevalent retinopathy. Our longitudinal results support the validity of the new hemoglobin A1c threshold of 6.5% or higher for diagnosing diabetes.